Weekly Digest – November 2024 Weekly Digest – November 2024 25 Nov 2024: Blenrep + BorDex combination accepted for review by US FDA The U.S. FDA has accepted GSK’s Biologics License Application (BLA) for the use of Blenrep (belantamab mafodotin) […]
Weekly Digest – November 2024 Weekly Digest – November 2024 27 Nov 2024: Sacituzumab Tirumotecan Earns Approval in China for Pretreated Advanced TNBC Sacituzumab tirumotecan has been approved by China’s National Medical Products Administration (NMPA) to treat adult patients with […]
Weekly Digest – November 2024 Weekly Digest – November 2024 28 Nov 2024: AstraZeneca’s Enhertu breast cancer drug added to China’s state insurance list AstraZeneca’s breast cancer drug, Enhertu, will be included in China’s state-run health insurance scheme starting January […]
